44 results on '"Blot, Emmanuel"'
Search Results
2. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial
3. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
4. Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial
5. Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial
6. TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
7. Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma
8. Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum‐based therapy: DIRECT
9. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
10. Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial
11. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy
12. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
13. Bulletin de synthèse de veille 2006: Standards, Options et Recommandations. Prise en charge des patients atteints de carcinome de site primitif inconnu
14. Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
15. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy
16. Carcinoma or Melanoma of an Unknown Primary?
17. CxCR4 Membrane Expression in Node-Negative Breast Cancer
18. Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients
19. Delay of Postoperative Radiotherapy in Head and Neck Cancer Patients
20. Chemoradiotherapy in Unresectable Squamous Cell Head and Neck Cancer
21. Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer
22. Immunotherapy for colon cancer
23. ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC).
24. Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate
25. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers
26. Abstract OT3-3-02: ASTER 70s UNICANCER phase III trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?
27. Assessing 2-month clinical prognosis in patients with solid tumors: Final results of PRONOPALL study.
28. Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
29. Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets
30. Retraction—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
31. Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate
32. RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
33. A Novel Mechanism of Action of Rivaroxaban: Inhibition of Monocyte and Macrophage Procoagulant Activity and Consequence On Inflammatory Process.
34. Erratum: A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
35. Molybdenum Contamination in Silicon: Detection and Impact on Device Performances
36. 2006 Monitoring Report: Clinical practice guidelines: the management of patients with carcinoma of unknown primary site
37. Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency
38. Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis
39. Apigenin inhibits endothelial-cell proliferation in G2/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression
40. Immunotherap y for colon cancer
41. Stimulation of angiogenesis resulting fromcooperation between macrophages and MDAMB-231 breast cancer cells: proposed molecularmechanism and effect of tetrathiomolybdate.
42. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
43. Elevated HER2 extracellular domain level in primary breast cancer with HER2 overexpression predicts early failure of adjuvant trastuzumab.
44. Clinical Improvement and Prolonged Survival With High Dose Intrathecal Methotrexate for Carcinomatous Meningitis Secondary to a Lung Adenocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.